Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 60%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 71% · prior close shown (market closed)
Bionano Genomics, Inc. shows stable business momentum based on AlphaOS pipeline evidence.
Why it matters: Revenue +21% YoY in Q2 FY2026.
3 signals not yet derived from pipeline evidence
What it means for the thesis — synthesis, not a raw event feed.
Pipeline evidence · 6d ago
BNGO's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on BNGO.
Free accounts see more of this; Premium sees all of it.
Reported figures for Bionano Genomics, Inc. — research only, not investment advice.
Updated
What happened recently for Bionano Genomics, Inc. (BNGO) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
BNGO's AI investment thesis
Upgrade to Premium for BNGO's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Prior close
$1.82
Market cap
$21.43M
Profitable
No
Revenue $8.17M
Net income
$-7.42M
FY Sep 15, 2026
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for Bionano Genomics, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow Bionano Genomics, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.